UNSPSC 51101664: Ipronidazole

This classification denotes an antiprotozoal agent with the molecular formula C7H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 045BU63E23, chemically known as 1h-imidazole, 2-isopropyl-1-methyl-5-nitro- but generally known as ipronidazole, which bears US NIH Compound Identifier 26951. European Medicines Agency schedules Ipronidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08284MIG.

UNSPSC 51101664 Ipronidazole, a Commodity code, represents pharmaceutical products and related supplies that state and local governments procure through piggyback contracts and competitive bidding. Recent activity shows state and local procurement offices and health departments buying pharmaceutical inventory — including antibiotics, opioid antagonists, and drug deactivation systems — through established cooperative purchasing frameworks and direct IFB processes. The issuing bodies span state-level health departments and county governments with public health and community health missions; these agencies typically structure purchases around annual supply needs with renewal options and quarterly or scheduled deliveries to designated facilities.

Recent opportunities include the Illinois Department of Public Health's award to Chartwell Rx LLC on August 28, 2026, for a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium supplying Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a $2,999,999.11 contract term (12 months initial with two renewal years), and Seminole County, Florida's IFB60459723LAS posted June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a July 26, 2023 response deadline. Activity concentrates in Florida and Illinois; both procurements emphasize compliance (E-Verify, drug-free workplace certification) and logistics (included shipping costs, quarterly or scheduled delivery to named facilities). Neither procurement required business enterprise or veterans program utilization, and neither applied domestic-product preferences.